173 related articles for article (PubMed ID: 35242669)
21. Pathologic study and clinical significance of Hürthle cell papillary thyroid carcinoma.
Mai KT; Thomas J; Yazdi HM; Commons AS; Lamba M; Stinson AW
Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):329-37. PubMed ID: 15536332
[TBL] [Abstract][Full Text] [Related]
22. Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors.
Tsybrovskyy O; De Luise M; de Biase D; Caporali L; Fiorini C; Gasparre G; Carelli V; Hackl D; Imamovic L; Haim S; Sobrinho-Simões M; Tallini G
J Pathol Clin Res; 2022 Mar; 8(2):155-168. PubMed ID: 34792302
[TBL] [Abstract][Full Text] [Related]
23. Comparison of histopathological features and prognosis of classical and follicular variant papillary thyroid carcinoma.
Tunca F; Sormaz IC; Iscan Y; Senyurek YG; Terzioglu T
J Endocrinol Invest; 2015 Dec; 38(12):1327-34. PubMed ID: 26280320
[TBL] [Abstract][Full Text] [Related]
24. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
Kazaure HS; Roman SA; Sosa JA
Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
[TBL] [Abstract][Full Text] [Related]
25. Impact of tall cell variant histology on predicting relapse and changing the management of papillary thyroid carcinoma patients.
Gunalp B; Okuyucu K; Ince S; Ayan A; Alagoz E
Hell J Nucl Med; 2017; 20(2):122-127. PubMed ID: 28697188
[TBL] [Abstract][Full Text] [Related]
26. Tall cell variant of papillary thyroid carcinoma: a population-based study in Iceland.
Axelsson TA; Hrafnkelsson J; Olafsdottir EJ; Jonasson JG
Thyroid; 2015 Feb; 25(2):216-20. PubMed ID: 25322334
[TBL] [Abstract][Full Text] [Related]
27. Higher incidence of tall cell variant of papillary thyroid carcinoma in Graves' Disease.
Boutzios G; Vasileiadis I; Zapanti E; Charitoudis G; Karakostas E; Ieromonachou P; Karatzas T
Thyroid; 2014 Feb; 24(2):347-54. PubMed ID: 23786233
[TBL] [Abstract][Full Text] [Related]
28. Ten percent tall cells confer the aggressive features of the tall cell variant of papillary thyroid carcinoma.
Beninato T; Scognamiglio T; Kleiman DA; Uccelli A; Vaca D; Fahey TJ; Zarnegar R
Surgery; 2013 Dec; 154(6):1331-6; discussion 1336. PubMed ID: 24238051
[TBL] [Abstract][Full Text] [Related]
29. Distinguishing tall cell variant of papillary thyroid carcinoma from usual variant of papillary thyroid carcinoma in cytologic specimens.
Solomon A; Gupta PK; LiVolsi VA; Baloch ZW
Diagn Cytopathol; 2002 Sep; 27(3):143-8. PubMed ID: 12203860
[TBL] [Abstract][Full Text] [Related]
30. BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis.
Li C; Lee KC; Schneider EB; Zeiger MA
J Clin Endocrinol Metab; 2012 Dec; 97(12):4559-70. PubMed ID: 23055546
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological Characteristics and Recurrence-Free Survival of Rare Variants of Papillary Thyroid Carcinomas in Korea: A Retrospective Study.
Kim M; Cho SW; Park YJ; Ahn HY; Kim HS; Suh YJ; Choi D; Kim BK; Yang GE; Park IS; Yi KH; Jung CK; Kim BH
Endocrinol Metab (Seoul); 2021 Jun; 36(3):619-627. PubMed ID: 34107674
[TBL] [Abstract][Full Text] [Related]
32. Clinical features and outcome of the tall cell variant of papillary thyroid carcinoma.
Leung AK; Chow SM; Law SC
Laryngoscope; 2008 Jan; 118(1):32-8. PubMed ID: 18025951
[TBL] [Abstract][Full Text] [Related]
33. Ultrasonographic Features of Papillary Thyroid Carcinomas According to Their Subtypes.
Baek HJ; Kim DW; Shin GW; Heo YJ; Baek JW; Lee YJ; Cho YJ; Park HK; Ha TK; Kim DH; Jung SJ; Park JS; Ahn KJ
Front Endocrinol (Lausanne); 2018; 9():223. PubMed ID: 29867759
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Significance of the Proportion of Tall Cell Components in Papillary Thyroid Carcinoma.
Ito Y; Hirokawa M; Miyauchi A; Higashiyama T; Kihara M; Miya A
World J Surg; 2017 Mar; 41(3):742-747. PubMed ID: 27807709
[TBL] [Abstract][Full Text] [Related]
35. Clinical Implication of Bilateral and Unilateral Multifocality in Papillary Thyroid Carcinoma: A Propensity Score-Matched Study.
Kim Y; An S; Park J; Bae JS; Kim JS; Kim K
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509259
[TBL] [Abstract][Full Text] [Related]
36. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
37. Coexistence of papillary thyroid carcinoma in secondary hyperparathyroidism.
Ma J; Mao Z; Yao Y; Lu Y; Wang H; Yang Y; Yang J; Wang W; Teng L
BMC Surg; 2021 Sep; 21(1):335. PubMed ID: 34488715
[TBL] [Abstract][Full Text] [Related]
38. Pathologic Reporting of Tall-Cell Variant of Papillary Thyroid Cancer: Have We Reached a Consensus?
Hernandez-Prera JC; Machado RA; Asa SL; Baloch Z; Faquin WC; Ghossein R; LiVolsi VA; Lloyd RV; Mete O; Nikiforov YE; Seethala RR; Suster S; Thompson LD; Turk AT; Sadow PM; Urken ML; Wenig BM
Thyroid; 2017 Dec; 27(12):1498-1504. PubMed ID: 29020884
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological and ultrasound features as risk stratification predictors of clinical and pathological nodal status in papillary thyroid carcinoma: a study of 748 patients.
Zhang C; Li B; Zhang L; Chen F; Zhang Y; Cheng W
BMC Cancer; 2022 Apr; 22(1):354. PubMed ID: 35365120
[TBL] [Abstract][Full Text] [Related]
40. Age of patients with papillary thyroid carcinoma: is it a key factor in the development of variants?
Das DK
Gerontology; 2005; 51(3):149-54. PubMed ID: 15832039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
